Genome Institute of Singapore and Roche announce collaboration on development of SARS detection kit
May
22 2003 - Genome Institute of Singapore and Roche Diagnostics announced
an agreement to co-develop a Severe Acute Respiratory Syndrome (SARS)
detection kit based on one of Roche's platform technologies - Polymerase
Chain Reaction (PCR) technology. SARS is a respiratory infection, caused
by a new strain of coronavirus, that has recently been reported in a
number of regions, including Singapore. Since its outbreak in March,
the Genome Institute of Singapore has been working to sequence the genetic
code of the SARS coronavirus and has defined its genetic diversity.
This information is critical to the development of robust diagnostic
assays.
The
diagnostic kit is expected to be ready... Please
click here for the full news release.
For
archive news, Please
click here for news release.